Product Program year 2020 Source: CMS Open Payments

Obtryx

Device Pelvic Organ Prolapse

Open in the dashboard

General payments

$11,523

246 payments

Research payments

$0

0 payments

Through program year 2020, $11,523 in general payments and $0 in research payments were reported against Obtryx (Pelvic Organ Prolapse).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $4,998 109
2019 General $6,525 137

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $11,523 246 payments
Top recipients General payments · program year 2020
  1. Victor Weinstein Obstetrics & Gynecology · Charleston, SC $114 2% · 1 payment
  2. Eduardo Martinez Urogynecology and Reconstructive Pelvic Surgery · Miami, FL $114 2% · 1 payment
  3. Kelly Shaffer Urology · North Charleston, SC $114 2% · 1 payment
  4. Steven Swift Urogynecology and Reconstructive Pelvic Surgery · Charleston, SC $114 2% · 1 payment
  5. Jonathan Donaldson Urology · Mt Pleasant, SC $114 2% · 1 payment

The top 5 of 93 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Obstetrics & Gynecology $2,679 55% · 45 practitioners
  2. Urology $881 18% · 25 practitioners
  3. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $782 16% · 8 practitioners
  4. Obstetrics Obstetrics & Gynecology $147 3% · 2 practitioners
  5. Urogynecology and Reconstructive Pelvic Surgery Urology $132 3% · 2 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. South Carolina $1,372 27% · 12 recipients
  2. Oklahoma $1,156 23% · 19 recipients
  3. Illinois $951 19% · 11 recipients
  4. Utah $662 13% · 17 recipients
  5. New York $198 4% · 2 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

246 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record